期刊文献+

丙泊酚靶浓度对开颅术中唤醒时间的影响 被引量:2

Awake craniotomy: effects of target concentration of propofol infusion on awake time and adverse events
在线阅读 下载PDF
导出
摘要 目的研究开颅术中唤醒时丙泊酚靶浓度对唤醒时间和不良事件发生率的影响。方法62例拟行大脑半球择期手术的患者在常规诱导后行经鼻气管内插管,然后随机将患者分为4组,其丙泊酚靶浓度分别设置为3.5、4.0、4.5和5.0μg/mL。所有患者诱导后不再使用其他镇痛药和麻醉药,只通过调整丙泊酚靶浓度来保证手术顺利进行,记录并比较各组患者(唤醒前丙泊酚靶浓度为5组:3.5、4.0、4.5、5.0和>5.0μg/mL)的唤醒时间和开颅期间的不良事件发生率。结果唤醒前丙泊酚靶浓度为3.5μg/mL组患者的唤醒时间与4μg/mL组的无显著性差异,但是较其他2组唤醒时间短(P<0.05)。对开颅期间不良事件发生率的分析显示,诱导后丙泊酚靶浓度为3.5μg/mL组患者的不良事件发生率明显高于其他3组。结论在开颅术中唤醒时,丙泊酚靶浓度能够明显影响患者的唤醒时间和开颅期间的不良事件发生率,在诱导后将丙泊酚靶浓度维持在4μg/mL是比较适宜的,既能使患者迅速被唤醒,又能使开颅期间的不良事件发生率比较低。 Objective To study the effects of different target concentration of propofol infusion on awake time and adverse events. Methods Sixty-two patients undergoing eraniotomy were randomly assigned to four groups in which the propofol target concentration was set at 3.5, 4.0, 4.5 and 5.0 μg/mL respectively after induction, and no more anesthetics were given besides increasing the concentration of propofol. So when the patients were asked to be waked up, the patients had been divided into 5 groups: 3. 5,4.0,4.5,5.0 and 〉 5.0 μg/mL. Awake time and adverse events were recorded. Results Awake time of the patients in the 3. 5 μg/mL and 4. 0 μg/mL groups was significantly shorter than that in other groups(P〈0.05). However, adverse events of the patients in the 3. 5 μg/mL group were significantly much more than those in other groups. Conclusions Propofol target concentration has significant effects on awake time and adverse events, and 4μg/mL is a suitable propofol target concentration after induction.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2008年第5期651-653,共3页 Fudan University Journal of Medical Sciences
基金 国家科技部"973"课题(2007CB12502)
关键词 开颅手术 唤醒试验 丙泊酚 靶控输注 craniotomy awake test propofol target eontrolled infusion
作者简介 Corresponding author E-mail:chiefliang@yahoo. com. cn
  • 相关文献

参考文献11

  • 1Hans P,Bonhomme V. Why we still use intravenous drugs as the basic regimen for neurosurgical anaesthesia[J]. Curr Opin Anaesthesiol, 2006,19 : 498 - 503.
  • 2Frost,Elizabeth AM,Booij ,et al. Anesthesia in the patient of awake craniotomy[J]. Curr Opin Anaesthesiol, 2007,20 : 331 - 335.
  • 3杨宁.靶控输注丙泊酚复合舒芬太尼静脉麻醉的药效学[C].广州:2005年全国麻醉学年会.
  • 4徐志鹏,刘芳,岳云,叶铁虎,张炳熙,左明章,徐铭军,郝绒绒,徐原,杨宁,车向明.性别和年龄对异丙酚-雷米芬太尼靶控输注下意识和疼痛反应消失EC_(50)及BIS值的影响——多中心研究[J].国际麻醉学与复苏杂志,2006,27(3):144-148. 被引量:10
  • 5吴群林,张兴安,王若松,聂煌.年龄对异丙酚药效学的影响[J].中华麻醉学杂志,2001,21(3):146-148. 被引量:41
  • 6Keifer JC, Dentchev D, Little K,et al. A retrospective analysis of a remifentanil/propofol general anesthetic for craniotomy before awake functional brain mapping [J]. Anesth Analg, 2(105,101 : 502 - 508
  • 7陈新忠,王保国,康孝荣,韩如泉,江涛,张建伟,张忠.大脑皮质功能区手术唤醒试验中异丙酚复合舒芬太尼或瑞芬太尼麻醉的效果[J].中华麻醉学杂志,2006,26(9):813-817. 被引量:38
  • 8Dinsmore J. Anaesthesia for elective neurosurgery[J]. Br J Anaesth ,2007,99:68 - 74.
  • 9Berkenstadt H, Perel A, Hadani M, et al. Monitored anesthesia care using remifentanll and propofol for awake craniotomy[J]. Neurosurg Anesthesiol, 2001 , 13 : 246 - 249.
  • 10Sarang A, Dinsmore J. Anaesthesia for awake craniotomy- evolution of a technique that facilitates awake neurological testing[J]. Br J Anaesth, 2003,90 : 161 - 165.

二级参考文献38

  • 1彭宇明,王保国.丙泊酚靶控输注的临床应用和研究进展[J].麻醉与监护论坛,2004,11(4):295-298. 被引量:1
  • 2江涛,陈新忠,谢坚,李子孝,梁雄利.功能区胶质瘤的术中直接电刺激判断核心手术技术[J].中国微侵袭神经外科杂志,2005,10(4):148-150. 被引量:74
  • 3王祥瑞,孙大金,杭燕南,许灿然,金正均.异丙酚的血药浓度与临床效应的关系[J].中华麻醉学杂志,1996,16(7):292-294. 被引量:67
  • 4Upton RN,Ludbrook GL,Grant C,et al. Cardiac output is a determinant of the initial concentrations of propofol after short-infusion administration. Anesth Analg, 1999,89 : 545-552.
  • 5Hoka S, Yamaura K, Takenaka T, et al. Propofol-induced increase in vascular capacitance is due to inhibition of sympathetic vasoconstrictive activity. Anesthesiology, 1998,89 : 1495-1500.
  • 6Sebel PS, Lowdon JD. Propofol: a new intravenous anesthetic.Anesthesiology, 1989,71 :260-277.
  • 7Tackley RM, Lewis GTR, Rrys-Roberts C, et al. Computer controlled infusion of propofol. Br J Anaesth, 1989,62 : 46- 53.
  • 8Glass PSA,Shafer SL, Reves JG. Intravenous drug delivery system. In Miller RD(ed) : Anesthesia,5th ed. New York, Churchill Livingstone, 2000,377-411.
  • 9Minto CF, Schnider TW, Egan TD,et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil: 1. model development. Anesthesiology, 1997 , 86( 1 ) :10-23.
  • 10Minto CF, Schnider TW, Shafer SL, et al. Pharmacokinetics and pharmacodynamics of remifentanil : Ⅱ. model application, Anesthesiology, 1997,86(1 ) : 24-33.

共引文献108

同被引文献25

  • 1张艺泷,米卫东.全静脉麻醉与静吸复合麻醉用于脊柱侧弯矫正术中唤醒的比较[J].解放军医学杂志,2006,31(5):480-481. 被引量:8
  • 2陈新忠,王保国,康孝荣,韩如泉,江涛,张建伟,张忠.大脑皮质功能区手术唤醒试验中异丙酚复合舒芬太尼或瑞芬太尼麻醉的效果[J].中华麻醉学杂志,2006,26(9):813-817. 被引量:38
  • 3周声汉,施冲,刘中华,曾因明.瑞芬太尼与芬太尼复合异丙酚在脑功能区手术唤醒麻醉中的应用[J].广东医学,2007,28(4):569-571. 被引量:12
  • 4Haglund MM, Berger MS, Shamseldin M ,et al. Cortical localization of temporal lobe language sites in patients with gliomas[ J]. Neurosurgery. 1994,34(4) :567 - 576.
  • 5Carrabba G,Venkatraghavan L,Bernstein M. Day surgery awake craniotomy for removing brain turnouts : technical note describing a simple protocol [ J ]. Minim Invas Neurosurg,2008,51 (4) : 208 - 210.
  • 6Jaaskelainen J, Randell T. Awake craniotomy in glioma surgery [ J]. Acta Neurochi Suppl,2003 ,88 :31 - 35.
  • 7Manninen PH ,Tan TK. Postoperative nausea and vomiting after eraniotomy for tumor surgery:a eomparison between awake eraniotomy and general anesthesia [ J]. J Clin Anesth ,2002,14 (4) :279 - 283.
  • 8Szelenyi A, Joksimovie B, Seifert V. Intraoperative risk of seizures assoeiated with transient direct cortical stimulation in patients with symptomatic epilepsy [J]. J Clin Neurophysiol,2007,24( 1 ) :39 -43.
  • 9Skucas AP,Artru AA. Anesthetic complications of awake craniotomies for epilepsy surgery [ J ]. Anesth Analg,2006,102 (3) :882 - 887.
  • 10Meyer FB, Bates LM, Goerss SJ,et al. Awake craniotomy for aggressive resection of primary glioraas located in eloquent brain [ J]. Mayo Clin Proe ,2001,76 (7) :677 - 687.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部